Solutions For Cell & Gene Therapy Manufacturing

Empowering cell and gene therapies to deliver life saving treatments

Activated T-cell therapies, such as CAR-T, TCR-T and gene therapies, are offering transformative outcomes for diseases. Recent CAR-T approvals and the growing number of clinical trials for these treatments are accelerating the process from discovery through clinical to commercial manufacturing and delivery.

As a trusted supplier for the top 20 biopharmaceutical companies, the expertise and capabilities Avantor® offers are focused on solving the complexities of this evolving landscape. Our high purity production chemicals, sterile fluid transfer systems, cell culture components and excipient technologies can help advance the scalability and manufacturability of viral vector production to cell and gene therapies, helping you bring life saving new cell therapy products to market, safely and effectively.